WASHINGTON, Dec. 20 - Despite promising discoveries and multibillion-dollar investments, cancer research is quietly undergoing a crisis. Federal drug regulators will soon announce several initiatives that they hope will help salvage the field.
Despite promising discoveries and multibillion-dollar investments, cancer research is quietly undergoing a crisis
WASHINGTON, Dec. 20 - Despite promising discoveries and multibillion-dollar investments, cancer research is quietly undergoing a crisis. Federal drug regulators will soon announce several initiatives that they hope will help salvage the field.